Free Webex Call
The animal pharmaceuticals market was valued USD45.23 billion in 2020 and is likely to grow with a steady CAGR of 7.05% in the forecast period to reach USD68.45 billion by 2026 due to the increase in pet adoption, rise in overall consumption of milk and meat, and fatal diseases like Ebola and swine flu spreading from animals. Animal pharmaceuticals are highly beneficial in the diagnosis and treatment of animal disorders. The emergence of new economies has led more governments and pharma companies to fund animal healthcare, consequently pushing the market forward. The restraining factors for the market can be the government rules regarding animal testing, and the probability of the sales of fake medicines across e-commerce platforms. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Animal Pharmaceuticals market is segmented based on product type, animal type, route of administration, type of infection, end-user, distribution channel and region. Based on product type, the market is segmented into drugs, vaccines and medicated feed. The drugs segment dominates the market due to the rise in diseases and various infections. On the basis of animal type, the market is segmented into companion and livestock animals. Companion animals tend to hold a larger share in the market as pet owners ensure their pet’s health and well-being. As compared to livestock animals, companion animals receive special care and veterinary treatment from their owners, which is the major factor driving the market share of this segment. Based on route of administration, the pharmaceutical products, i.e., drugs and medicated feed are given orally hence the oral route of administration dominates the market. Viral infections dominate the type of infection segment pertaining to their ease of spread and rate of infection. Veterinary clinics are expected to grow at a faster rate because they provide specialized pet/ livestock treatment however, veterinary hospitals are still likely to dominate the end-user segment. Based on distribution channel, e-commerce segment is expected to grow at a faster rate in the future because of continuous technological advancements that make it the most convenient option for pet and livestock owners.
The overall animal pharmaceuticals market is widespread, expanding itself to various regions including Asia-Pacific, Europe, North America, South America, and Middle East & Africa. North America has the largest market share by virtue of the pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. However, the fastest growth is shown by the Asia-Pacific region due to the prevalence of animal-borne diseases like swine flu and Ebola.
The top leading players of the animal pharmaceuticals market are Zoetis Inc, Merck and Company, Vetoquinol SA, Virbac SA, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc, Ceva Sante Animale S.A., Covetrus Inc., Phibro Animal Health Corporation, Biogénesis Bagó SA, Neogen Corporation Ltd., Dechra Pharmaceuticals PLC, ImmuCell Corporation, Krka, tovarna zdravil, d. d., Novo mesto, and ECO Animal Health Ltd., etc. The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus enhancing the animal healthcare sector.
Years considered for this report:
- Historical Years: 2016-2019
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022-2026F
Objective of the Study:
- To analyze the historical growth in the market size of the Global Animal Pharmaceuticals market from 2016 to 2020.
- To estimate and forecast the market size of the Global Animal Pharmaceuticals market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast the Global Animal Pharmaceuticals market based on product type, animal type, route of administration, type of infection, end-user, distribution channel and region.
- To identify drivers and challenges for the Global Animal Pharmaceuticals market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Animal Pharmaceuticals market.
- To conduct pricing analysis for the Global Animal Pharmaceuticals market.
- To identify and analyze the profile of leading players operating in the Global Animal Pharmaceuticals market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of service providers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher was able to include the service providers which could not be identified due to the limitations of secondary research. The publisher analyzed the service providers, distribution channels and presence of all major players across the globe.
The publisher calculated the market size of the Global Animal Pharmaceuticals market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.
Key Target Audience:
- Animal healthcare centers, vets
- Research organizations and consulting companies
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to animal pharmaceuticals
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.
Report Scope:
In this report, the Global Animal Pharmaceuticals market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Global Animal Pharmaceuticals Market, By Product Type:
- Drugs
- Vaccines
- Medicated Feed
Global Animal Pharmaceuticals Market, By Animal Type:
- Companion Animal
- Livestock Animal
Global Animal Pharmaceuticals Market, By Route of Administration:
- Oral
- Parenteral
- Topical
Global Animal Pharmaceuticals Market, By Type of Infection:
- Viral
- Bacterial
- Parasitic
- Others
Global Animal Pharmaceuticals Market, By End-User:
- Veterinary Hospitals
- Veterinary Clinics
- Point of Care/ In-house Testing
- Others
Global Animal Pharmaceuticals Market, By Distribution Channel:
- Veterinary Hospitals
- Pharmacies and Drug stores
- E-commerce
Global Animal Pharmaceuticals Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- Australia
- Japan
- China
- India
- South Korea
- South America
- Argentina
- Brazil
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
- Company Profiles: Detailed analysis of the major companies present in the Global Animal Pharmaceuticals market.
Available Customizations:
With the given market data, the publisher offers customizations according to a client’s specific needs.
Table of Contents
1. Product Overview2. Research Methodology
3. Impact of COVID-19 on Global Animal Pharmaceuticals Market
4. Executive Summary
5. Voice of Customer
5.1. Factors Driving the Growth of Global Animal Pharmaceuticals Market
5.2. Factors Influencing Purchase Decision
5.3. Brand Awareness
6. Global Animal Pharmaceuticals Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Drugs, Vaccines, Medicated Feed)
6.2.2. By Animal Type (Companion animal, Livestock animal)
6.2.3. By Route of Administration (Oral, Parenteral, Topical)
6.2.4. By Type of Infection (Viral, Bacterial, Parasitic, Others)
6.2.5. By End User (Veterinary Hospitals, Veterinary Clinics, Point of care/In-house testing, Others)
6.2.6. By Distribution Channel (Veterinary Hospitals, Pharmacies and Drug stores, E-commerce)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Product Market Map
7. North America Animal Pharmaceuticals Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Animal Type
7.2.3. By Route of Administration
7.2.4. By Type of Infection
7.2.5. By End User
7.2.6. By Distribution Channel
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Animal Pharmaceuticals Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Animal Type
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By Type of Infection
7.3.1.2.5. By End User
7.3.1.2.6. By Distribution Channel
7.3.2. Canada Animal Pharmaceuticals Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Animal Type
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By Type of Infection
7.3.2.2.5. By End User
7.3.2.2.6. By Distribution Channel
7.3.3. Mexico Animal Pharmaceuticals Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Animal Type
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By Type of Infection
7.3.3.2.5. By End User
7.3.3.2.6. By Distribution Channel
8. Europe Animal Pharmaceuticals Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Animal Type
8.2.3. By Route of Administration
8.2.4. By Type of Infection
8.2.5. By End User
8.2.6. By Distribution Channel
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Animal Pharmaceuticals Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Animal Type
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By Type of Infection
8.3.1.2.5. By End User
8.3.1.2.6. By Distribution Channel
8.3.2. United Kingdom Animal Pharmaceuticals Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Animal Type
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By Type of Infection
8.3.2.2.5. By End User
8.3.2.2.6. By Distribution Channel
8.3.3. France Animal Pharmaceuticals Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Animal Type
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By Type of Infection
8.3.3.2.5. By End User
8.3.3.2.6. By Distribution Channel
8.3.4. Italy Animal Pharmaceuticals Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Animal Type
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By Type of Infection
8.3.4.2.5. By End User
8.3.4.2.6. By Distribution Channel
8.3.5. Spain Animal Pharmaceuticals Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Animal Type
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By Type of Infection
8.3.5.2.5. By End User
8.3.5.2.6. By Distribution Channel
9. Asia-Pacific Animal Pharmaceuticals Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Animal Type
9.2.3. By Route of Administration
9.2.4. By Type of Infection
9.2.5. By End User
9.2.6. By Distribution Channel
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. Australia Animal Pharmaceuticals Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Animal Type
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By Type of Infection
9.3.1.2.5. By End User
9.3.1.2.6. By Distribution Channel
9.3.2. Japan Animal Pharmaceuticals Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Animal Type
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By Type of Infection
9.3.2.2.5. By End User
9.3.2.2.6. By Distribution Channel
9.3.3. China Animal Pharmaceuticals Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Animal Type
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By Type of Infection
9.3.3.2.5. By End User
9.3.3.2.6. By Distribution Channel
9.3.4. India Animal Pharmaceuticals Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product Type
9.3.4.2.2. By Animal Type
9.3.4.2.3. By Route of Administration
9.3.4.2.4. By Type of Infection
9.3.4.2.5. By End User
9.3.4.2.6. By Distribution Channel
9.3.5. South Korea Animal Pharmaceuticals Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product Type
9.3.5.2.2. By Animal Type
9.3.5.2.3. By Route of Administration
9.3.5.2.4. By Type of Infection
9.3.5.2.5. By End User
9.3.5.2.6. By Distribution Channel
10. South America Animal Pharmaceuticals Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Animal Type
10.2.3. By Route of Administration
10.2.4. By Type of Infection
10.2.5. By End User
10.2.6. By Distribution Channel
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Argentina Animal Pharmaceuticals Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Animal Type
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By Type of Infection
10.3.1.2.5. By End User
10.3.1.2.6. By Distribution Channel
10.3.2. Brazil Animal Pharmaceuticals Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Animal Type
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By Type of Infection
10.3.2.2.5. By End User
10.3.2.2.6. By Distribution Channel
10.3.3. Colombia Animal Pharmaceuticals Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Animal Type
10.3.3.2.3. By Route of Administration
10.3.3.2.4. By Type of Infection
10.3.3.2.5. By End User
10.3.3.2.6. By Distribution Channel
11. Middle East and Africa Animal Pharmaceuticals Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product Type
11.2.2. By Animal Type
11.2.3. By Route of Administration
11.2.4. By Type of Infection
11.2.5. By End User
11.2.6. By Distribution Channel
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Animal Pharmaceuticals Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product Type
11.3.1.2.2. By Animal Type
11.3.1.2.3. By Route of Administration
11.3.1.2.4. By Type of Infection
11.3.1.2.5. By End User
11.3.1.2.6. By Distribution Channel
11.3.2. Saudi Arabia Animal Pharmaceuticals Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product Type
11.3.2.2.2. By Animal Type
11.3.2.2.3. By Route of Administration
11.3.2.2.4. By Type of Infection
11.3.2.2.5. By End User
11.3.2.2.6. By Distribution Channel
11.3.3. UAE Animal Pharmaceuticals Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product Type
11.3.3.2.2. By Animal Type
11.3.3.2.3. By Route of Administration
11.3.3.2.4. By Type of Infection
11.3.3.2.5. By End User
11.3.3.2.6. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Zoetis Inc
14.2.2. Merck & Company Inc.
14.2.3. Boehringer Ingelheim GmbH
14.2.4. Elanco Animal Health Inc.
14.2.5. Vetoquinol SA
14.2.6. Virbac SA
14.2.7. Phibro Animal Health Corporation
14.2.8. Ceva Sante Animale S.A
14.2.9. Covetrus Inc.
14.2.10. Biogénesis Bagó SA
14.2.11. Neogen Corporation Ltd.
14.2.12. Dechra Pharmaceuticals PLC
14.2.13. ImmuCell Corporation
14.2.14. Krka, tovarna zdravil, d. d., Novo mesto
14.2.15. ECO Animal Health Ltd.
15. Strategic Recommendations
16. About the Publisher & DisclaimerList of Figures
Figure 1: Global Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 3: Global Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 4: Global Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 5: Global Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 6: Global Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 7: Global Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 8: Global Animal Pharmaceuticals Market, By Region, By Value, 2016-2026F
Figure 9: Global Animal Pharmaceuticals Market, Market Map, By Value, 2016-2026F
Figure 10: North America Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 11: North America Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 12: North America Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 13: North America Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 14: North America Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 15: North America Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 16: North America Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 17: North America Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
Figure 18: United States Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 19: United States Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 20: United States Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 21: United States Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 22: United States Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 23: United States Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 24: United States Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 25: Canada Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 26: Canada Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 27: Canada Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 28: Canada Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 29: Canada Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 30: Canada Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 31: Canada Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 32: Mexico Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 33: Mexico Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 34: Mexico Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 35: Mexico Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 36: Mexico Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 37: Mexico Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 38: Mexico Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 39: Europe Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 40: Europe Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 41: Europe Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 42: Europe Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 43: Europe Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 44: Europe Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 45: Europe Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 46: Europe Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
Figure 47: Germany Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 48: Germany Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 49: Germany Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 50: Germany Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 51: Germany Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 52: Germany Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 53: Germany Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 54: United Kingdom Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 55: United Kingdom Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 56: United Kingdom Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 57: United Kingdom Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 58: United Kingdom Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 59: United Kingdom Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 60: United Kingdom Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 61: France Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 62: France Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 63: France Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 64: France Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 65: France Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 66: France Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 67: France Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 68: Italy Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 69: Italy Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 70: Italy Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 71: Italy Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 72: Italy Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 73: Italy Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 74: Italy Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 75: Spain Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 76: Spain Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 77: Spain Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 78: Spain Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 79: Spain Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 80: Spain Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 81: Spain Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 82: Asia-Pacific Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 83: Asia-Pacific Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 84: Asia-Pacific Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 85: Asia-Pacific Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 86: Asia-Pacific Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 87: Asia-Pacific Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 88: Asia-Pacific Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 89: Asia-Pacific Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
Figure 90: Australia Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 91: Australia Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 92: Australia Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 93: Australia Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 94: Australia Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 95: Australia Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 96: Australia Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 97: Japan Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 98: Japan Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 99: Japan Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 100: Japan Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 101: Japan Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 102: Japan Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 103: Japan Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 104: China Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 105: China Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 106: China Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 107: China Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 108: China Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 109: China Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 110: China Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 111: India Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 112: India Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 113: India Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 114: India Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 115: India Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 116: India Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 117: India Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 118: South Korea Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 119: South Korea Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 120: South Korea Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 121: South Korea Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 122: South Korea Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 123: South Korea Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 124: South Korea Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 125: South America Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 126: South America Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 127: South America Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 128: South America Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 129: South America Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 130: South America Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 131: South America Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 132: South America Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
Figure 133: Argentina Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 134: Argentina Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 135: Argentina Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 136: Argentina Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 137: Argentina Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 138: Argentina Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 139: Argentina Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 140: Brazil Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 141: Brazil Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 142: Brazil Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 143: Brazil Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 144: Brazil Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 145: Brazil Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 146: Brazil Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 147: Colombia Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 148: Colombia Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 149: Colombia Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 150: Colombia Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 151: Colombia Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 152: Colombia Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 153: Colombia Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 154: Middle East and Africa Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 155: Middle East and Africa Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 156: Middle East and Africa Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 157: Middle East and Africa Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 158: Middle East and Africa Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 159: Middle East and Africa Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 160: Middle East and Africa Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 161: Middle East and Africa Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F
Figure 162: South Africa Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 163: South Africa Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 164: South Africa Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 165: South Africa Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 166: South Africa Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 167: South Africa Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 168: South Africa Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 169: Saudi Arabia Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 170: Saudi Arabia Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 171: Saudi Arabia Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 172: Saudi Arabia Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 173: Saudi Arabia Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 174: Saudi Arabia Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 175: Saudi Arabia Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 176: UAE Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F
Figure 177: UAE Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F
Figure 178: UAE Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F
Figure 179: UAE Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F
Figure 180: UAE Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F
Figure 181: UAE Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F
Figure 182: UAE Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Zoetis Inc
- Merck & Company Inc.
- Boehringer Ingelheim GmbH
- Elanco Animal Health Inc.
- Vetoquinol SA
- Virbac SA
- Phibro Animal Health Corporation
- Ceva Sante Animale S.A
- Covetrus Inc.
- Biogénesis Bagó SA
- Neogen Corporation Ltd.
- Dechra Pharmaceuticals PLC
- ImmuCell Corporation
- Krka, tovarna zdravil, d. d., Novo mesto
- ECO Animal Health Ltd
Table Information
| Report Attribute | Details |
|---|---|
| Published | June 2021 |
| Forecast Period | 2016 - 2026 |
| Estimated Market Value ( USD | $ 36.74 Billion |
| Forecasted Market Value ( USD | $ 68.45 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
